In fostering an excellent work culture and staff performance, the Executive Management of the Institute of Human Virology Nigeria (IHVN) has initiated the “Employee Recognition Awards” to recognize “Employees of the Month” and “Employee of the Year.”
According to the IHVN Director of Finance and Administration, Mr. Olu Alabi, this recognition covers overall employee performance in dressing, innovation, teamwork, productivity, efficiency, leadership and interpersonal skills, punctuality, and adherence to company values and principles, amongst other things.
For February 2025, IHVN Celebrates, Ademola Blessing Ajayi, Temitope Olukomogbon, Vincent Emmanuel, Kwaghe Kwalgha Jonah, Stanley Idakwo, Chigolum-Chidi David-Onuoha.
Abubakar Iliyasu Bichi and Paschal Lojah whose performance stood out in their teams.
Three hearty cheers to our February star performers!
The Institute of Human Virology Nigeria (IHVN) has expressed its continued commitment to ending tuberculosis in Nigeria through the expansion of tuberculosis (TB) case detection, community-based interventions and leveraging digital innovation.
Project Director of the Global Fund Tuberculosis and HIV Grant at the Institute, Dr. Olayemi Olupitan stated this at the pre-World TB Day press briefing in Abuja. She said that the Institute utilized Global Fund support from 2021 -2023 to optimize over 400 Gene Xpert diagnostic sites and is currently supporting the deployment of more than 190 portable digital Xray systems enabled with artificial intelligence for TB screening in high burden areas.
“Between 2021-2024 alone, IHVN-supported facilities tested 3.5 million individuals leading to the detection and notification of more than 350,000 tuberculosis cases, contributing to the country’s national case notification targets. The integration of digital screening tools, such as the Mobile Application for TB Screening (MATS), has further enhanced TB reporting from the private sector.”
Dr. Olupitan explained that the public-private partnership initiative championed by the Institute has resulted in capacity building and engagement of 15,000 patent and proprietary medicine vendors, 1000 pharmacists, 4,000 private hospitals and faith-based clinics and 1000 traditional healers and birth attendants in tuberculosis diagnosis, treatment and community screening.
“Under the Global Fund 2024-2026 Grant, strengthening TB and HIV integration is a key priority. In 2024 alone, over 270,000 pregnant women were screened for TB and HIV in both community settings and unconventional sites enabling early diagnosis and initiation of prevention therapy were necessary.”
Also at the press briefing, the Executive Secretary of the Global Fund Country Coordinating Mechanism, Mr. Ibrahim Tajudeen stressed the need for sufficient funding to address tuberculosis in Nigeria.
Stakeholders at the briefing including the Chairman of the House Committee on HIV/AIDS, Tuberculosis and Malaria, Mr. Amobi Ogah, Director of Public Health, Dr. Godwin Ntadom, Representative of the World Health Organization in Nigeria, Dr. Mya Sapal and the Acting Board Chairman of Stop TB Partnership in Nigeria, Dr. Queen Ogbuji, all assured Nigerians of their commitment to ending tuberculosis in Nigeria.
According to the 2024 World Health Organization Global Tuberculosis Report, Nigeria ranks first in Africa and sixth globally among the 30 high burden tuberculosis countries. The theme for this year’s commemoration is “Yes! We Can End TB – Commit, Invest, Deliver. Apart from press-briefings, other activities to commemorate the day include, community outreach and sensitization activities and a road show.
Project Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria, Grant Cycle-7 TB &HIV grant, and the GF Nigeria TB-HIV Reach, Integration & Impact Project (N-THRIP), Dr. Olayemi Olupitan participating as a panelist in the pre-World TB Day press briefingA cross section of panelists and dignitaries at the event.
